Login or Sign Up
Concord Biotech Ltd. Deals
15:57 Jul 18
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:57 Jul 18
Quality
68/100
High Financial Strength
Valuation
28/100
Expensive Valuation
Technical
54/100
Technically Neutral
Strength
12
Weakness
2
Opportunity
0
Threats
1
0.00 %
Dividend Yield
19.81K
Market Cap (Cr)
58.03
RSI
44.08 %
Promoter Holding
30.96 %
Net Profit Margin
| Client | Date | Avg Price | Qty | Value(Cr) | Action |
|---|
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
